Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (301-310 of 519) with videos related to

Pageof 52
Sort By:
Prostate Cancer and Prostatic Diseases|July 11, 2018
Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapiesKaren S Sfanos, Mark C Markowski, Lauren B Peiffer, et al.
Cancer Research|October 3, 2007
Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivoRobert D Loberg, Chi Ying, Matt Craig, et al.
JAMA|April 3, 2002
alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancerMark A Rubin, Ming Zhou, Saravana M Dhanasekaran, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2009
Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell traffickingSteven R Barthel, Georg K Wiese, Jaehyung Cho, et al.
The Prostate|July 22, 2014
Frequent discordance between ERG gene rearrangement and ERG protein expression in a rapid autopsy cohort of patients with lethal, metastatic, castration-resistant prostate cancerAaron M Udager, Yang Shi, Scott A Tomlins, et al.
Plos One|May 3, 2013
GAS6 receptor status is associated with dormancy and bone metastatic tumor formationRussell S Taichman, Lalit R Patel, Rachel Bedenis, et al.
Neoplasia (New York, N.Y.)|September 24, 2016
DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer MetastasisEunsohl Lee, Jingcheng Wang, Kenji Yumoto, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
Low-Level Endogenous PSMA Expression in Nonprostatic Tumor Xenografts Is Sufficient for In Vivo Tumor Targeting and ImagingSridhar Nimmagadda, Mrudula Pullambhatla, Ying Chen, et al.
The Prostate|September 20, 2017
Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy MeetingAndrea K Miyahira, Heather H Cheng, Wassim Abida, et al.
Clinical & Experimental Metastasis|June 16, 2023
Cells in the polyaneuploid cancer cell (PACC) state have increased metastatic potentialMikaela M Mallin, Nicholas Kim, Mohammad Ikbal Choudhury, et al.
Pageof 52

Showing results (301-310 of 519) with videos related to

Sort By:
Pageof 52
Prostate Cancer and Prostatic Diseases|July 11, 2018
Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapiesKaren S Sfanos, Mark C Markowski, Lauren B Peiffer, et al.
Cancer Research|October 3, 2007
Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivoRobert D Loberg, Chi Ying, Matt Craig, et al.
JAMA|April 3, 2002
alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancerMark A Rubin, Ming Zhou, Saravana M Dhanasekaran, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2009
Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell traffickingSteven R Barthel, Georg K Wiese, Jaehyung Cho, et al.
The Prostate|July 22, 2014
Frequent discordance between ERG gene rearrangement and ERG protein expression in a rapid autopsy cohort of patients with lethal, metastatic, castration-resistant prostate cancerAaron M Udager, Yang Shi, Scott A Tomlins, et al.
Plos One|May 3, 2013
GAS6 receptor status is associated with dormancy and bone metastatic tumor formationRussell S Taichman, Lalit R Patel, Rachel Bedenis, et al.
Neoplasia (New York, N.Y.)|September 24, 2016
DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer MetastasisEunsohl Lee, Jingcheng Wang, Kenji Yumoto, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
Low-Level Endogenous PSMA Expression in Nonprostatic Tumor Xenografts Is Sufficient for In Vivo Tumor Targeting and ImagingSridhar Nimmagadda, Mrudula Pullambhatla, Ying Chen, et al.
The Prostate|September 20, 2017
Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy MeetingAndrea K Miyahira, Heather H Cheng, Wassim Abida, et al.
Clinical & Experimental Metastasis|June 16, 2023
Cells in the polyaneuploid cancer cell (PACC) state have increased metastatic potentialMikaela M Mallin, Nicholas Kim, Mohammad Ikbal Choudhury, et al.
Pageof 52